Deutsche Bank Ag\ Theravance Biopharma, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 30,942 shares of TBPH stock, worth $308,491. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,942

Previous 22,061 40.26%

Holding current value

$308,491

Previous $187,000 33.16%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.66 - $10.25 $68,028 - $91,030	8,881 Added 40.26%	30,942 $249,000
Q2 2024 Aug 14, 2024	SELL	$8.29 - $9.92 $47,841 - $57,248	-5,771 Reduced 20.74%	22,061 $187,000
Q1 2024 May 15, 2024	BUY	$8.22 - $11.59 $3,559 - $5,018	433 Added 1.58%	27,832 $249,000
Q4 2023 Feb 14, 2024	SELL	$8.58 - $11.4 $6,314 - $8,390	-736 Reduced 2.62%	27,399 $307,000
Q3 2023 Nov 09, 2023	BUY	$8.38 - $10.44 $34,676 - $43,200	4,138 Added 17.24%	28,135 $242,000
Q2 2023 Aug 14, 2023	SELL	$10.16 - $11.92 $242,732 - $284,780	-23,891 Reduced 49.89%	23,997 $248,000
Q1 2023 May 15, 2023	BUY	$9.87 - $11.44 $58,519 - $67,827	5,929 Added 14.13%	47,888 $519,000
Q4 2022 Feb 13, 2023	BUY	$9.65 - $11.34 $114,796 - $134,900	11,896 Added 39.57%	41,959 $470,000
Q3 2022 Nov 14, 2022	SELL	$8.39 - $10.22 $88,187 - $107,422	-10,511 Reduced 25.91%	30,063 $305,000
Q2 2022 Aug 11, 2022	SELL	$8.41 - $10.34 $15,070 - $18,529	-1,792 Reduced 4.23%	40,574 $368,000
Q1 2022 May 13, 2022	SELL	$8.33 - $12.96 $29,179 - $45,398	-3,503 Reduced 7.64%	42,366 $406,000
Q4 2021 Feb 11, 2022	BUY	$7.42 - $11.05 $42,798 - $63,736	5,768 Added 14.38%	45,869 $507,000
Q3 2021 Nov 04, 2021	BUY	$6.77 - $14.41 $19,382 - $41,255	2,863 Added 7.69%	40,101 $297,000
Q2 2021 Aug 11, 2021	SELL	$14.52 - $22.46 $2.43 Million - $3.75 Million	-167,048 Reduced 81.77%	37,238 $541,000
Q1 2021 May 13, 2021	SELL	$16.57 - $21.08 $177,050 - $225,239	-10,685 Reduced 4.97%	204,286 $4.17 Million
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $696,420 - $942,903	-46,771 Reduced 17.87%	214,971 $3.82 Million
Q3 2020 Nov 12, 2020	SELL	$14.79 - $22.49 $3.26 Million - $4.95 Million	-220,279 Reduced 45.7%	261,742 $3.87 Million
Q2 2020 Aug 13, 2020	BUY	$20.64 - $30.69 $116,306 - $172,938	5,635 Added 1.18%	482,021 $10.1 Million
Q1 2020 May 14, 2020	BUY	$17.84 - $31.21 $7.76 Million - $13.6 Million	434,938 Added 1049.36%	476,386 $11 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $25.89 $459,726 - $738,356	28,519 Added 220.58%	41,448 $1.07 Million
Q3 2019 Nov 14, 2019	SELL	$16.51 - $23.78 $239,626 - $345,142	-14,514 Reduced 52.89%	12,929 $250,000
Q2 2019 Aug 14, 2019	SELL	$15.6 - $25.15 $451,635 - $728,117	-28,951 Reduced 51.34%	27,443 $446,000
Q1 2019 May 15, 2019	BUY	$22.57 - $28.15 $90,280 - $112,600	4,000 Added 7.63%	56,394 $1.28 Million
Q4 2018 Feb 14, 2019	SELL	$22.52 - $35.07 $3.16 Million - $4.93 Million	-140,498 Reduced 72.84%	52,394 $1.34 Million
Q3 2018 Dec 21, 2021	BUY	$22.83 - $32.67 $538,354 - $770,391	23,581 Added 13.93%	192,892 $6.3 Million
Q3 2018 Nov 14, 2018	BUY	$22.83 - $32.67 $1.09 Million - $1.57 Million	47,941 Added 39.5%	169,311 $5.53 Million
Q2 2018 Apr 21, 2020	BUY	$22.06 - $25.52 $507,225 - $586,781	22,993 Added 23.37%	121,370 $2.75 Million
Q2 2018 Aug 14, 2018	SELL	$22.06 - $25.52 $240,851 - $278,627	-10,918 Reduced 9.99%	98,377 $2.23 Million
Q1 2018 Oct 18, 2019	BUY	$23.37 - $29.71 $575,696 - $731,876	24,634 Added 29.1%	109,295 $2.65 Million
Q1 2018 May 15, 2018	SELL	$23.37 - $29.71 $562,959 - $715,684	-24,089 Reduced 22.15%	84,661 $2.05 Million
Q4 2017 Feb 14, 2018	BUY	$25.82 - $35.66 $1.27 Million - $1.75 Million	49,137 Added 82.43%	108,750 $3.03 Million
Q3 2017 Nov 14, 2017	BUY	$23.88 - $34.96 $1.42 Million - $2.08 Million	59,613	59,613 $2.04 Million

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $666M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account